Exicure logo
Exicure
XCUR | NASDAQ
Chart Builder DCF Calculator
$1.07
-$0.01 (-0.93%)
At close: Nov 16, 2026, 4:00 PM ET
$1.12
+$0.05 (+4.67%)
After-hours: Nov 16, 2026, 7:30 PM ET

Exicure Company Profile

Company profile explained

Company Profile

Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.

Key Executives

Name Position
Jungsoo Kim Chief Executive Officer, President & Director
Young Seung Ko Chief Operating Officer
Devki Sukhtankar Head of Preclinical Research & Translational Medicine
Gyuyeob Lee Interim CFO & Secretary
Joshua Miller Chief Accounting Officer
Niña Caculitan Head of Clinical

Latest SEC Filings

Date Type Title
Sep 16, 2026 8-K Current Report
Aug 14, 2026 10-Q Quarterly Report
Jul 17, 2026 4 Filing
Jul 17, 2026 SC 13D/A [Amend] Filing
Jun 30, 2026 8-K Current Report
Jun 01, 2026 8-K Current Report
May 29, 2026 10-Q Quarterly Report
May 15, 2026 NT 10-Q Filing
Apr 10, 2026 8-K Current Report
Apr 02, 2026 8-K Current Report
View All SEC Filings ➞
Exicure
Exicure logo
Country United States
IPO Date May 22, 2018
Industry Biotechnology
Sector Healthcare
Employees 1
CEO Jungsoo Kim

Contact Details

400 Seaport Court Redwood City, California 94063 United States

Stock Details

Ticker Symbol XCUR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001698530
CUSIP Number 30205M309
ISIN Number US30205M3097
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.